SYNERGIC POSTANTIBIOTIC EFFECT OF MECILLINAM, IN COMBINATION WITH OTHER BETA-LACTAM ANTIBIOTICS IN RELATION TO MORPHOLOGY AND INITIAL KILLING

被引:12
|
作者
HANBERGER, H [1 ]
NILSSON, LE [1 ]
SVENSSON, E [1 ]
MALLER, R [1 ]
机构
[1] LINKOPING UNIV HOSP,DEPT CLIN BACTERIOL,S-58185 LINKOPING,SWEDEN
关键词
D O I
10.1093/jac/28.4.523
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The synergic in-vitro post-antibiotic effect (PAE) of mecillinam, in combination with either ampicillin, aztreonam, ceftazidime or piperacillin, on a reference strain of Escherichia coli was evaluated by bioluminescence assay of bacterial ATP. Ampicillin, ceftazidime and mecillinam alone induced a concentration dependent PAE (> 3 h) on E. coli, whereas aztreonam and piperacillin alone induced a short (< 1 h) non-dose dependent PAE. At most concentrations, the combination of mecillinam and ampicillin, aztreonam, ceftazidime or piperacillin induced longer PAEs on E. coli than the sum of the individual antibiotics' PAEs. Long PAEs were seen concomitantly with the presence of spheroplasts. In addition to the synergistic PAE, the decrease in colony counts and changes in ATP values after a 2 h exposure to mecillinam, in combination with the other β-lactam antibiotics, were more prominent than the respective values after exposure to the individual antibiotics. The change in ATP was generally less pronounced than the decrease in colony counts. This could be due to lysis of spheroplasts on agar plates, leading to an over-estimation of the initial killing when assayed by viable counting. Mecillinam, which induced long PAEs on E. coli at almost all concentrations in this study, has a high affinity for penicillin binding protein 2 (PBP 2) and induced spheroplast formation at all concentrations. However, mechanisms other than the affinity for PBP 2 and spheroplast formation are involved in the PAE of β-lactam antibiotics on Gram-negative bacteria; since the PAE was prolonged when mecillinam was combined with ampicillin, aztreonam, ceftazidime or piperacillin, which bind preferentially to PBP 1 and 3. © 1991, by The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:523 / 532
页数:10
相关论文
共 50 条
  • [1] POSTANTIBIOTIC EFFECT OF BETA-LACTAM ANTIBIOTICS ON GRAM-NEGATIVE BACTERIA IN RELATION TO MORPHOLOGY, INITIAL KILLING AND MIC
    HANBERGER, H
    NILSSON, LE
    NILSSON, M
    MALLER, R
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (11) : 927 - 934
  • [2] PHARMACODYNAMICS OF BETA-LACTAM ANTIBIOTICS ON GRAM-NEGATIVE BACTERIA - INITIAL KILLING, MORPHOLOGY AND POSTANTIBIOTIC EFFECT
    HANBERGER, H
    NILSSON, LE
    MALLER, R
    NILSSON, M
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1991, : 118 - 123
  • [4] SYNERGIC POSTANTIBIOTIC EFFECT OF AMIKACIN IN COMBINATION WITH BETA-LACTAM ANTIBIOTICS ON GRAM-NEGATIVE BACTERIA
    ISAKSSON, B
    HANBERGER, H
    MALLER, R
    NILSSON, LE
    NILSSON, M
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 (01) : 25 - 34
  • [5] SYNERGY OF MECILLINAM AND CLAVULANIC ACID WITH OTHER BETA-LACTAM ANTIBIOTICS
    SJOBERG, B
    EKSTROM, B
    FORSGREN, U
    MAGNI, L
    PRING, BG
    INFECTION, 1978, 6 : S17 - S23
  • [6] EFFECT OF TEMOCILLIN IN COMBINATION WITH OTHER BETA-LACTAM ANTIBIOTICS
    VERBIST, L
    VERHAEGEN, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (01) : 142 - 144
  • [7] INVITRO SYNERGY OF MECILLINAM WITH BETA-LACTAM ANTIBIOTICS
    CHATTOPADHYAY, B
    HALL, I
    MICROBIOS LETTERS, 1978, 7 (26): : 87 - 95
  • [8] THE INVITRO ACTIVITY OF MECILLINAM ALONE AND IN COMBINATION WITH OTHER BETA LACTAM ANTIBIOTICS
    MANY, WJ
    RUDERMAN, AE
    SOUTHERN, PM
    LUBY, JP
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1982, 31 (03): : 475 - 484
  • [9] SYNERGIC INTERACTIONS INVOLVING BETA-LACTAM ANTIBIOTICS
    GREENWOOD, D
    THERAPIE, 1978, 33 (04): : 532 - 532
  • [10] SYNERGISTIC POSTANTIBIOTIC EFFECT OF AMIKACIN AND BETA-LACTAM ANTIBIOTICS ON ENTEROCOCCUS-FAECALIS
    ISAKSSON, B
    HANBERGER, H
    MALLER, R
    NILSSON, LE
    NILSSON, M
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 : 9 - 14